BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26485842)

  • 1. AN INITIAL INDICATION OF PREDISPOSING RISK OF SCHISTOSOMA MANSONI INFECTION FOR HEPATOCELLULAR CARCINOMA.
    Sabry Ael H; El-Aal AA; Mahmoud NS; Nabil Y; Aziz IZ
    J Egypt Soc Parasitol; 2015 Aug; 45(2):233-40. PubMed ID: 26485842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosoma mansoni infection: is it a risk factor for development of hepatocellular carcinoma?
    El-Tonsy MM; Hussein HM; Helal Tel-S; Tawfik RA; Koriem KM; Hussein HM
    Acta Trop; 2013 Dec; 128(3):542-7. PubMed ID: 23932944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.
    Hassan MM; Zaghloul AS; El-Serag HB; Soliman O; Patt YZ; Chappell CL; Beasley RP; Hwang LY
    J Clin Gastroenterol; 2001 Aug; 33(2):123-6. PubMed ID: 11468438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.
    Kamal S; Madwar M; Bianchi L; Tawil AE; Fawzy R; Peters T; Rasenack JW
    Liver; 2000 Jul; 20(4):281-9. PubMed ID: 10959806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis.
    Badawi AF; Michael MS
    Anticancer Res; 1999; 19(5C):4565-9. PubMed ID: 10650811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective.
    El-Tonsy MM; Hussein HM; Helal Tel-S; Tawfik RA; Koriem KM; Hussein HM
    J Parasit Dis; 2016 Sep; 40(3):976-80. PubMed ID: 27605822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of schistosomiasis and hepatitis on liver disease.
    Halim AB; Garry RF; Dash S; Gerber MA
    Am J Trop Med Hyg; 1999 Jun; 60(6):915-20. PubMed ID: 10403320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Shousha HI; Abdelaziz AO; Nabeel MM; Omran DA; Abdelmaksoud AH; Elbaz TM; Salah A; Harb STE; Hosny KA; Osman A; Atef M; Gaber A; Zayed NA; Yosry AA; Leithy R
    Pathog Glob Health; 2022 Mar; 116(2):119-127. PubMed ID: 34494507
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatocellular carcinoma associated with chronic Schistosoma mansoni infection in a chimpanzee.
    Abe K; Kagei N; Teramura Y; Ejima H
    J Med Primatol; 1993 Jun; 22(4):237-9. PubMed ID: 8230173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does
    von Bülow V; Lichtenberger J; Grevelding CG; Falcone FH; Roeb E; Roderfeld M
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt.
    el-Sayed HF; Abaza SM; Mehanna S; Winch PJ
    Acta Trop; 1997 Nov; 68(2):229-37. PubMed ID: 9386797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma.
    Mabrouk GM
    Dis Markers; 1997 Nov; 13(3):177-82. PubMed ID: 9405930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.
    el-Kady IM; el-Masry SA; Badra G; Halafawy KA
    Egypt J Immunol; 2004; 11(1):23-9. PubMed ID: 15724383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.
    El-Moamly AA; El-Sweify MA; Rashad RM; Abdalla EM; Ragheb MM; Awad MM
    Parasitol Res; 2013 Jul; 112(7):2745-52. PubMed ID: 23515570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosomal liver fibrosis and hepatocellular carcinoma - case series of patients submitted to liver transplantation.
    Filgueira NA; Saraiva CMA; Jucá NT; Bezerra MF; Lacerda CM
    Braz J Infect Dis; 2018; 22(4):352-354. PubMed ID: 30017854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.
    Ezzat S; Abdel-Hamid M; Eissa SA; Mokhtar N; Labib NA; El-Ghorory L; Mikhail NN; Abdel-Hamid A; Hifnawy T; Strickland GT; Loffredo CA
    Int J Hyg Environ Health; 2005; 208(5):329-39. PubMed ID: 16217918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.